Sep. 10 at 1:47 PM
$VEEV Veeva Systems (VEEV)
• Conference commentary: At the Wells Fargo 21st Annual Healthcare Conference (Sept 9), Veeva outlined a strategy expanding from life‑sciences CRM into data, R&D software, and AI.[investing]
• Institutional flows: Recent 13F filings show big moves: CalSTRS increased its stake by ~16,590% in Q2; Saudi Central Bank boosted its position by 78.5%.[marketbeat +1]
• Sentiment/targets: Consensus rating is “Moderate Buy” with an average price target around
$285.[marketbeat]
What to watch: How management frames AI monetization in life sciences, CRM growth vs. new data/R&D modules, and any updates on commercial cloud adoption.